Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 170 articles:
HTML format
Text format



Single Articles


    October 2018
  1. MA C, Ascoytia C, McCarrier KP, Martin M, et al
    Physicians' Perspectives on Cost, Safety, and Perceived Efficacy Determine Aminosalicylate Use in Crohn's Disease.
    Dig Dis Sci. 2018;63:2555-2563.
    PubMed     Text format     Abstract available


  2. NASSER Y, Labetoulle R, Harzallah I, Berger AE, et al
    Comparison of Point-of-Care and Classical Immunoassays for the Monitoring Infliximab and Antibodies Against Infliximab in IBD.
    Dig Dis Sci. 2018;63:2714-2721.
    PubMed     Text format     Abstract available


  3. KEDIA S, Jain S, Goyal S, Bopanna S, et al
    Potential of Fecal Calprotectin as an Objective Marker to Discriminate Hospitalized Patients with Acute Severe Colitis from Outpatients with Less Severe Disease.
    Dig Dis Sci. 2018;63:2747-2753.
    PubMed     Text format     Abstract available


  4. PATIL SA, Cross RK
    More Skin in the Game: Screening for Skin Cancer in IBD Patients.
    Dig Dis Sci. 2018;63:2497-2499.
    PubMed     Text format    


  5. LEE D, Swan CK, Suskind D, Wahbeh G, et al
    Children with Crohn's Disease Frequently Consume Select Food Additives.
    Dig Dis Sci. 2018;63:2722-2728.
    PubMed     Text format     Abstract available


    September 2018
  6. CHIOCCHETTI A, Prodam F, Dianzani U
    Homocysteine and Folate in Inflammatory Bowel Disease: Can Reducing Sulfur Reduce Suffering?
    Dig Dis Sci. 2018 Sep 6. pii: 10.1007/s10620-018-5274.
    PubMed     Text format    


  7. SCHIFF ER, Frampton M, Semplici F, Bloom SL, et al
    A New Look at Familial Risk of Inflammatory Bowel Disease in the Ashkenazi Jewish Population.
    Dig Dis Sci. 2018 Sep 3. pii: 10.1007/s10620-018-5219.
    PubMed     Text format     Abstract available


  8. FIORUCCI S, Biagioli M, Distrutti E
    Immunephenotype Predicts Response to Vedolizumab: Integrating Clinical and Biochemical Biomarkers in the Treatment of Inflammatory Bowel Diseases.
    Dig Dis Sci. 2018;63:2168-2171.
    PubMed     Text format    


  9. KIM ES, Kim SK, Jang BI, Kim KO, et al
    Disease Activity Patterns Recorded Using a Mobile Monitoring System Are Associated with Clinical Outcomes of Patients with Crohn's Disease.
    Dig Dis Sci. 2018;63:2220-2230.
    PubMed     Text format     Abstract available


    August 2018
  10. SHIN DS, Cheon JH, Park YE, Park Y, et al
    Extensive Disease Subtypes in Adult Patients with Ulcerative Colitis: Non-pancolitis Versus Pancolitis.
    Dig Dis Sci. 2018 Aug 25. pii: 10.1007/s10620-018-5218.
    PubMed     Text format     Abstract available


  11. MICIC D, Yarur A, Gonsalves A, Rao VL, et al
    Correction to: Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study.
    Dig Dis Sci. 2018 Aug 22. pii: 10.1007/s10620-018-5249.
    PubMed     Text format     Abstract available


  12. LI Y, Xu H, Xu T, Xiao M, et al
    Case-Control Study of Inflammatory Bowel Disease Patients with and without Clostridium difficile Infection and Poor Outcomes in Patients Coinfected with C. difficile and Cytomegalovirus.
    Dig Dis Sci. 2018 Aug 9. pii: 10.1007/s10620-018-5230.
    PubMed     Text format     Abstract available


    July 2018
  13. CHABLANI SV, Ramos-Rivers C, Binion DG, Szigethy E, et al
    Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance and Healthcare Utilization in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jul 19. pii: 10.1007/s10620-018-5194.
    PubMed     Text format    


  14. BAR-GIL SHITRIT A, Chen-Shuali C, Adar T, Koslowsky B, et al
    Sleep Disturbances Can Be Prospectively Observed in Patients with an Inactive Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jul 19. pii: 10.1007/s10620-018-5207.
    PubMed     Text format     Abstract available


  15. JUNCADELLA A, Papamichael K, Vaughn BP, Cheifetz AS, et al
    Maintenance Adalimumab Concentrations Are Associated with Biochemical, Endoscopic, and Histologic Remission in Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jul 13. pii: 10.1007/s10620-018-5202.
    PubMed     Text format     Abstract available


  16. CHANG JY, Cheon JH, Park Y, Park SJ, et al
    Does Medical Acceleration Improve Outcomes in Ulcerative Colitis Patients Who Are in Clinical Remission but Have Endoscopic Inflammation?
    Dig Dis Sci. 2018 Jul 9. pii: 10.1007/s10620-018-5193.
    PubMed     Text format     Abstract available


  17. SITKIN S, Pokrotnieks J
    Alterations in Polyunsaturated Fatty Acid Metabolism and Reduced Serum Eicosadienoic Acid Level in Ulcerative Colitis: Is There a Place for Metabolomic Fatty Acid Biomarkers in IBD?
    Dig Dis Sci. 2018 Jul 9. pii: 10.1007/s10620-018-5182.
    PubMed     Text format    


  18. DAMAS OM, Estes D, Avalos D, Quintero MA, et al
    Hispanics Coming to the US Adopt US Cultural Behaviors and Eat Less Healthy: Implications for Development of Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jul 7. pii: 10.1007/s10620-018-5185.
    PubMed     Text format     Abstract available


  19. AL-TAWEEL T, Strohl M, Pai M, Martel M, et al
    A Study of Optimal Screening for Latent Tuberculosis in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jul 3. pii: 10.1007/s10620-018-5178.
    PubMed     Text format     Abstract available


  20. LING C, Gavin M, Hanson J, McCarthy DM, et al
    Progressive Epigastric Pain with Abnormal Liver Tests in a Patient with Crohn's Disease: Don't DILI Dally.
    Dig Dis Sci. 2018;63:1751-1755.
    PubMed     Text format    


  21. LIAN L, Huang Q, Zhang L, Qin H, et al
    Anti-fibrogenic Potential of Mesenchymal Stromal Cells in Treating Fibrosis in Crohn's Disease.
    Dig Dis Sci. 2018;63:1821-1834.
    PubMed     Text format     Abstract available


    June 2018
  22. ZHU H, Huang S, Yue M, Chen W, et al
    Dysregulated Up-Frameshift Protein 1 Promotes Ulcerative Colitis Pathogenesis Through the TNFR1-NF-kappaB/MAPKs Pathway.
    Dig Dis Sci. 2018 Jun 29. pii: 10.1007/s10620-018-5171.
    PubMed     Text format     Abstract available


  23. VEDAMURTHY A, Xu L, Luther J, Colizzo F, et al
    Long-Term Outcomes of Immunosuppression-Naive Steroid Responders Following Hospitalization for Ulcerative Colitis.
    Dig Dis Sci. 2018 Jun 27. pii: 10.1007/s10620-018-5176.
    PubMed     Text format     Abstract available


  24. ANDERSON AJM, Ferris LK, Binion DG, Smith KJ, et al
    Cost-Effectiveness of Melanoma Screening in Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jun 13. pii: 10.1007/s10620-018-5141.
    PubMed     Text format     Abstract available


  25. WANG P, Hu J, Ghadermarzi S, Raza A, et al
    Smoking and Inflammatory Bowel Disease: A Comparison of China, India, and the USA.
    Dig Dis Sci. 2018 Jun 4. pii: 10.1007/s10620-018-5142.
    PubMed     Text format     Abstract available


  26. ARORA U, Kedia S, Garg P, Bopanna S, et al
    Colonic Crohn's Disease Is Associated with Less Aggressive Disease Course Than Ileal or Ileocolonic Disease.
    Dig Dis Sci. 2018;63:1592-1599.
    PubMed     Text format     Abstract available


  27. ELURI S, Cross RK, Martin C, Weinfurt KP, et al
    Inflammatory Bowel Diseases Can Adversely Impact Domains of Sexual Function Such as Satisfaction with Sex Life.
    Dig Dis Sci. 2018;63:1572-1582.
    PubMed     Text format     Abstract available


  28. KOK B, Lester ELW, Lee WM, Hanje AJ, et al
    Acute Liver Failure from Tumor Necrosis Factor-alpha Antagonists: Report of Four Cases and Literature Review.
    Dig Dis Sci. 2018;63:1654-1666.
    PubMed     Text format     Abstract available


    May 2018
  29. ABRAHAM BP, Quigley EMM
    A Probiotic for Ulcerative Colitis: The Culture Wars Continue.
    Dig Dis Sci. 2018 May 21. pii: 10.1007/s10620-018-5097.
    PubMed     Text format    


  30. CHANDRADAS S, Khalili H, Ananthakrishnan A, Wayman C, et al
    Does Obesity Influence the Risk of Clostridium difficile Infection Among Patients with Ulcerative Colitis?
    Dig Dis Sci. 2018 May 19. pii: 10.1007/s10620-018-5108.
    PubMed     Text format     Abstract available


  31. COHEN-MEKELBURG S, Tafesh Z, Coburn E, Weg R, et al
    Testing and Treating Small Intestinal Bacterial Overgrowth Reduces Symptoms in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 May 14. pii: 10.1007/s10620-018-5109.
    PubMed     Text format     Abstract available


  32. WEIZMAN AV, Sharma R, Afzal NM, Xu W, et al
    Stricturing and Fistulizing Crohn's Disease Is Associated with Anti-tumor Necrosis Factor-Induced Psoriasis in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 May 8. pii: 10.1007/s10620-018-5096.
    PubMed     Text format     Abstract available


  33. UZZAN M
    Concise Commentary: Calling in Your Marker-Rectal CD30-Positive Cells Differentiate Ulcerative Colitis from Crohn's Disease.
    Dig Dis Sci. 2018 May 3. pii: 10.1007/s10620-018-5099.
    PubMed     Text format    


  34. CHETCUTI ZAMMIT S, McAlindon ME, Hale MF, Sidhu R, et al
    Isolated Terminal Ileitis: When Is It Not Crohn's Disease?
    Dig Dis Sci. 2018;63:1367.
    PubMed     Text format    


  35. MOGILEVSKI T, Sparrow MP
    Infliximab Versus Adalimumab in Patients with Biologic-Naive Crohn's Disease: Is the Difference Real?
    Dig Dis Sci. 2018;63:1094-1096.
    PubMed     Text format    


  36. BENMASSAOUD A, Al-Taweel T, Sasson MS, Moza D, et al
    Comparative Effectiveness of Infliximab Versus Adalimumab in Patients with Biologic-Naive Crohn's Disease.
    Dig Dis Sci. 2018;63:1302-1310.
    PubMed     Text format     Abstract available


    April 2018
  37. ANDERSON A, Ferris LK, Click B, Ramos-Rivers C, et al
    Low Rates of Dermatologic Care and Skin Cancer Screening Among Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2018 Apr 30. pii: 10.1007/s10620-018-5056.
    PubMed     Text format     Abstract available


  38. PERERA LP, Bhandari S, Liu R, Guilday C, et al
    Advanced Age Does Not Negatively Impact Health-Related Quality of Life in Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Apr 30. pii: 10.1007/s10620-018-5076.
    PubMed     Text format     Abstract available


  39. BAR-GIL SHITRIT A, Cohen Y, Hassin O, Ben Ya'acov A, et al
    Correction to: Antenatal Management for Women with Inflammatory Bowel Disease: Experience from Our 'IBD MOM' Clinic.
    Dig Dis Sci. 2018 Apr 27. pii: 10.1007/s10620-018-5084.
    PubMed     Text format     Abstract available


  40. SHAH R, Ho EY, Kramer JR, Richardson P, et al
    Hepatitis B Virus Screening and Reactivation in a National VA Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Antagonists.
    Dig Dis Sci. 2018 Apr 16. pii: 10.1007/s10620-018-5042.
    PubMed     Text format     Abstract available


  41. LIMSRIVILAI J, Rao K, Stidham RW, Govani SM, et al
    Systemic Inflammatory Responses in Ulcerative Colitis Patients and Clostridium difficile Infection.
    Dig Dis Sci. 2018 Apr 12. pii: 10.1007/s10620-018-5044.
    PubMed     Text format     Abstract available


  42. SHITRIT AB, Cohen Y, Hassin O, Ya'acov AB, et al
    Antenatal Management for Women with Inflammatory Bowel Disease: Experience from Our 'IBD MOM' Clinic.
    Dig Dis Sci. 2018 Apr 6. pii: 10.1007/s10620-018-5048.
    PubMed     Text format     Abstract available


  43. CAVOUNIDIS A, Uhlig HH
    Crohn's Disease in Niemann-Pick Disease Type C1: Caught in the Cross-Fire of Host-Microbial Interactions.
    Dig Dis Sci. 2018;63:811-813.
    PubMed     Text format    


  44. LING J, Buurman D, Ravikumara M, Mews C, et al
    Accelerated Step-Up Infliximab Use Is Associated with Sustained Primary Response in Pediatric Crohn's Disease.
    Dig Dis Sci. 2018;63:1003-1010.
    PubMed     Text format     Abstract available


  45. CICCONE F, Ciccone A, Di Ruscio M, Vernia F, et al
    IgG4-Related Disease Mimicking Crohn's Disease: A Case Report and Review of Literature.
    Dig Dis Sci. 2018;63:1072-1086.
    PubMed     Text format    


  46. NOBEL YR, Axelrad J, Lewis SK, Whittier S, et al
    Stool PCR for Gastrointestinal Pathogens in Patients With and Without Immune-Mediated Intestinal Diseases.
    Dig Dis Sci. 2018;63:996-1002.
    PubMed     Text format     Abstract available


  47. COUGNOUX A, Movassaghi M, Picache JA, Iben JR, et al
    Gastrointestinal Tract Pathology in a BALB/c Niemann-Pick Disease Type C1 Null Mouse Model.
    Dig Dis Sci. 2018;63:870-880.
    PubMed     Text format     Abstract available


    March 2018
  48. AVALOS DJ, Mendoza-Ladd A, Zuckerman MJ, Bashashati M, et al
    Hispanic Americans and Non-Hispanic White Americans Have a Similar Inflammatory Bowel Disease Phenotype: A Systematic Review with Meta-Analysis.
    Dig Dis Sci. 2018 Mar 29. pii: 10.1007/s10620-018-5022.
    PubMed     Text format     Abstract available


  49. CALDERA F, Saha S, Wald A, Garmoe CA, et al
    Lower Sustained Diphtheria and Pertussis Antibody Concentrations in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2018 Mar 29. pii: 10.1007/s10620-018-5043.
    PubMed     Text format     Abstract available


  50. KERLIN AM, Long M, Kappelman M, Martin C, et al
    Profiles of Patients Who Use Marijuana for Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Mar 29. pii: 10.1007/s10620-018-5040.
    PubMed     Text format     Abstract available


  51. HOLMSTROM RB, Mogensen DV, Brynskov J, Ainsworth MA, et al
    Interactions Between Thiopurine Metabolites, Adalimumab, and Antibodies Against Adalimumab in Previously Infliximab-Treated Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Mar 21. pii: 10.1007/s10620-018-5020.
    PubMed     Text format     Abstract available


  52. BERRY N, Sinha SK, Bhattacharya A, Prasad KK, et al
    Role of Positron Emission Tomography in Assessing Disease Activity in Ulcerative Colitis: Comparison with Biomarkers.
    Dig Dis Sci. 2018 Mar 21. pii: 10.1007/s10620-018-5026.
    PubMed     Text format     Abstract available


  53. NISHIUMI S, Izumi Y, Yoshida M
    Alterations in Docosahexaenoic Acid-Related Lipid Cascades in Inflammatory Bowel Disease Model Mice.
    Dig Dis Sci. 2018 Mar 21. pii: 10.1007/s10620-018-5025.
    PubMed     Text format     Abstract available


  54. FABIAN O, Hradsky O, Drskova T, Mikus F, et al
    Immunohistochemical Assessment of CD30+ Lymphocytes in the Intestinal Mucosa Facilitates Diagnosis of Pediatric Ulcerative Colitis.
    Dig Dis Sci. 2018 Mar 14. pii: 10.1007/s10620-018-5018.
    PubMed     Text format     Abstract available


  55. KUSAKA J, Shiga H, Kuroha M, Kimura T, et al
    Residual Lesions on Capsule Endoscopy Is Associated with Postoperative Clinical Recurrence in Patients with Crohn's Disease.
    Dig Dis Sci. 2018;63:768-774.
    PubMed     Text format     Abstract available


  56. LUTHER J, Gala M, Patel SJ, Dave M, et al
    Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn's Disease Is Not Associated with Emergence of Novel Inflammatory Pathways.
    Dig Dis Sci. 2018;63:738-745.
    PubMed     Text format     Abstract available


    February 2018
  57. FLEISHER M, Marsal J, Lee SD, Frado LE, et al
    Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Feb 26. pii: 10.1007/s10620-018-4971.
    PubMed     Text format     Abstract available


  58. MAK WY, Buisson A, Andersen MJ Jr, Lei D, et al
    Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2018 Feb 22. pii: 10.1007/s10620-018-4980.
    PubMed     Text format     Abstract available


  59. KIELY CJ, Clark A, Bhattacharyya J, Moran GW, et al
    Acetarsol Suppositories: Effective Treatment for Refractory Proctitis in a Cohort of Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Feb 19. pii: 10.1007/s10620-017-4890.
    PubMed     Text format     Abstract available


  60. MATSUOKA K, Uemura Y, Kanai T, Kunisaki R, et al
    Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis.
    Dig Dis Sci. 2018 Feb 15. pii: 10.1007/s10620-018-4946.
    PubMed     Text format     Abstract available


  61. MICIC D, Yarur A, Gonsalves A, Rao VL, et al
    Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study.
    Dig Dis Sci. 2018 Feb 8. pii: 10.1007/s10620-018-4941.
    PubMed     Text format     Abstract available


    January 2018
  62. FERNANDEZ-BLANCO JI, Fernandez-Diaz G, Cara C, Vera MI, et al
    Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis.
    Dig Dis Sci. 2018 Jan 25. pii: 10.1007/s10620-018-4935.
    PubMed     Text format     Abstract available


  63. BODEN EK, Shows DM, Chiorean MV, Lord JD, et al
    Identification of Candidate Biomarkers Associated with Response to Vedolizumab in Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jan 25. pii: 10.1007/s10620-018-4924.
    PubMed     Text format     Abstract available


  64. LUKACH AJ, Saul MI, Ferris LK, Swoger JM, et al
    Risk Factors for Hidradenitis Suppurativa in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jan 22. pii: 10.1007/s10620-018-4919.
    PubMed     Text format     Abstract available


  65. FEUERSTEIN JD, Curran T, Alosilla M, Cataldo T, et al
    Mortality Is Rare Following Elective and Non-elective Surgery for Ulcerative Colitis, but Mild Postoperative Complications Are Common.
    Dig Dis Sci. 2018 Jan 20. pii: 10.1007/s10620-018-4922.
    PubMed     Text format     Abstract available


  66. ANDRADE P, Lopes S, Gaspar R, Nunes A, et al
    Anti-Tumor Necrosis Factor-alpha-Induced Dermatological Complications in a Large Cohort of Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2018 Jan 18. pii: 10.1007/s10620-018-4921.
    PubMed     Text format     Abstract available


  67. PAPAMICHAEL K, Vajravelu RK, Osterman MT, Cheifetz AS, et al
    Long-Term Outcome of Infliximab Optimization for Overcoming Immunogenicity in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jan 16. pii: 10.1007/s10620-018-4917.
    PubMed     Text format     Abstract available


  68. OSAMURA A, Suzuki Y
    Fourteen-Year Anti-TNF Therapy in Crohn's Disease Patients: Clinical Characteristics and Predictive Factors.
    Dig Dis Sci. 2018;63:204-208.
    PubMed     Text format     Abstract available


  69. NGUYEN VQ, Mays JL, Lang M, Wu Y, et al
    Knowledge Gaps in the Management of Postoperative Crohn's Disease: A US National Survey.
    Dig Dis Sci. 2018;63:53-60.
    PubMed     Text format     Abstract available


    December 2017
  70. SHAMAH S, Schneider J, Korelitz BI
    High Incidence of Recurrent Crohn's Disease Following Colectomy for Ulcerative Colitis Revealed with Long Follow-Up.
    Dig Dis Sci. 2017 Dec 28. pii: 10.1007/s10620-017-4873.
    PubMed     Text format     Abstract available


  71. GIUFFRIDA P, Corazza GR, Di Sabatino A
    Old and New Lymphocyte Players in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Dec 23. pii: 10.1007/s10620-017-4892.
    PubMed     Text format     Abstract available


    November 2017
  72. FEUERSTEIN JD, Papamichael K, Popejoy S, Nadelson A, et al
    Targeted Physician Education and Standardizing Documentation Improves Documented Reporting with Inflammatory Bowel Disease Quality Measures in a Large Academic and Private Practice.
    Dig Dis Sci. 2017 Nov 17. doi: 10.1007/s10620-017-4845.
    PubMed     Text format     Abstract available


  73. GURVITS GE
    Lax Prophylaxis: Vaccinating the Inflammatory Bowel Disease Patient.
    Dig Dis Sci. 2017 Nov 10. doi: 10.1007/s10620-017-4836.
    PubMed     Text format    


  74. FISCHER M, Campbell SC, Calley CSJ, Helper DJ, et al
    Risk Factors for Rescue Therapy in Crohn's Patients Maintained on Infliximab After Withdrawal of the Immunomodulator: A Long-Term Follow-Up.
    Dig Dis Sci. 2017;62:3131-3137.
    PubMed     Text format     Abstract available


  75. HAR-NOY O, Katz L, Avni T, Battat R, et al
    Chromoendoscopy, Narrow-Band Imaging or White Light Endoscopy for Neoplasia Detection in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2017;62:2982-2990.
    PubMed     Text format     Abstract available


    October 2017
  76. MORSHEDZADEH N, Rahimlou M, Asadzadeh Aghdaei H, Shahrokh S, et al
    Association Between Adipokines Levels with Inflammatory Bowel Disease (IBD): Systematic Reviews.
    Dig Dis Sci. 2017 Oct 30. doi: 10.1007/s10620-017-4806.
    PubMed     Text format     Abstract available


  77. TSE CS, Deepak P, Smyrk TC, Raffals LE, et al
    Isolated Acute Terminal Ileitis Without Preexisting Inflammatory Bowel Disease Rarely Progresses to Crohn's Disease.
    Dig Dis Sci. 2017 Oct 24. doi: 10.1007/s10620-017-4803.
    PubMed     Text format     Abstract available


  78. FINE S, Nee J, Thakuria P, Duff B, et al
    Ocular, Auricular, and Oral Manifestations of Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Oct 24. doi: 10.1007/s10620-017-4781.
    PubMed     Text format     Abstract available


  79. CAMPBELL JP, Burton E, Wymer S, Shaw M, et al
    Out-of-Pocket Cost Is a Barrier to Therapeutic Drug Monitoring in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Oct 20. doi: 10.1007/s10620-017-4808.
    PubMed     Text format     Abstract available


  80. CALLOWAY A, Dalal R, Beaulieu DB, Duley C, et al
    Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Oct 20. doi: 10.1007/s10620-017-4800.
    PubMed     Text format     Abstract available


  81. DAI C, Jiang M, Sun MJ
    Fecal Calprotectin in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Oct 17. doi: 10.1007/s10620-017-4799.
    PubMed     Text format    


  82. LINARES PM, Algaba A, Urzainqui A, Guijarro-Rojas M, et al
    Ratio of Circulating Estrogen Receptors Beta and Alpha (ERbeta/ERalpha) Indicates Endoscopic Activity in Patients with Crohn's Disease.
    Dig Dis Sci. 2017;62:2744-2754.
    PubMed     Text format     Abstract available


  83. SEO H, Ye BD, Song EM, Lee SH, et al
    Long-Term Outcomes of Adalimumab Treatment in 254 Patients with Crohn's Disease: A Hospital-Based Cohort Study from Korea.
    Dig Dis Sci. 2017;62:2882-2893.
    PubMed     Text format     Abstract available


  84. LI J, Yan Y, Meng Z, Liu S, et al
    Microscopic Colitis Evolved Into Inflammatory Bowel Diseases Is Characterized by Increased Th1/Tc1 Cells in Colonic Mucosal Lamina Propria.
    Dig Dis Sci. 2017;62:2755-2767.
    PubMed     Text format     Abstract available


    September 2017
  85. PUOLANNE AM, Kolho KL, Alfthan H, Ristimaki A, et al
    Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Sep 25. doi: 10.1007/s10620-017-4770.
    PubMed     Text format     Abstract available


  86. HUSSEY M, Holleran G, Smith S, Sherlock M, et al
    The Role and Regulation of the 11 Beta-Hydroxysteroid Dehydrogenase Enzyme System in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Sep 20. doi: 10.1007/s10620-017-4753.
    PubMed     Text format     Abstract available


  87. HAAS L, Chevalier R, Major BT, Enders F, et al
    Biologic Agents Are Associated with Excessive Weight Gain in Children with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Sep 11. doi: 10.1007/s10620-017-4745.
    PubMed     Text format     Abstract available


  88. KUMAR V, Shah Y, Patel D, Khan N, et al
    Elderly-Onset and Adult-Onset Ulcerative Colitis Are More Similar than Previously Reported in a Nationwide Cohort.
    Dig Dis Sci. 2017 Sep 7. doi: 10.1007/s10620-017-4734.
    PubMed     Text format     Abstract available


  89. DE BARROS KSC, Flores C, Harlacher L, Francesconi CFM, et al
    Evolution of Clinical Behavior in Crohn's Disease: Factors Associated with Complicated Disease and Surgery.
    Dig Dis Sci. 2017;62:2481-2488.
    PubMed     Text format     Abstract available


  90. BELLOLIO ROTH F, Gomez J, Cerda J
    Increase in Hospital Discharges for Inflammatory Bowel Diseases in Chile Between 2001 and 2012.
    Dig Dis Sci. 2017;62:2311-2317.
    PubMed     Text format     Abstract available


  91. SHAH A, Talley NJ, Walker M, Koloski N, et al
    Is There a Link Between H. Pylori and the Epidemiology of Crohn's Disease?
    Dig Dis Sci. 2017;62:2472-2480.
    PubMed     Text format     Abstract available


    August 2017
  92. CASTANEDA G, Liu B, Torres S, Bhuket T, et al
    Race/Ethnicity-Specific Disparities in the Severity of Disease at Presentation in Adults with Ulcerative Colitis: A Cross-Sectional Study.
    Dig Dis Sci. 2017 Aug 30. doi: 10.1007/s10620-017-4733.
    PubMed     Text format     Abstract available


  93. POURAFKARI L, Masnadi-Shirazi K, Taban M, Mohammadi S, et al
    Higher Frequency of Nocturnal Blood Pressure Dipping but Not Heart Rate Dipping in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Aug 23. doi: 10.1007/s10620-017-4712.
    PubMed     Text format     Abstract available


  94. PHAM HV, Hasan I, Udaltsova N, Pham K, et al
    Rates and Predictors of Vaccinations Among Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Agents.
    Dig Dis Sci. 2017 Aug 23. doi: 10.1007/s10620-017-4716.
    PubMed     Text format     Abstract available


  95. ZIZZO MG, Serio R
    Therapeutic Potential of the Gabaergic System in Ulcerative Colitis: Current Status and Perspectives.
    Dig Dis Sci. 2017 Aug 5. doi: 10.1007/s10620-017-4709.
    PubMed     Text format    


  96. CARRASCO A, Fernandez-Banares F
    Th1 Pathway: The Missing Link Between Inflammatory Bowel Disease and Microscopic Colitis?
    Dig Dis Sci. 2017 Aug 3. doi: 10.1007/s10620-017-4692.
    PubMed     Text format    


  97. ALLOCCA M, Fiorino G, Danese S
    Biosimilar Drugs for Inflammatory Bowel Disease: Is Similar Good Enough?
    Dig Dis Sci. 2017 Aug 3. doi: 10.1007/s10620-017-4693.
    PubMed     Text format    


  98. KAMAT N, Ganesh Pai C, Surulivel Rajan M, Kamath A, et al
    Cost of Illness in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Aug 1. doi: 10.1007/s10620-017-4690.
    PubMed     Text format     Abstract available


  99. BAFFORD AC, Latushko A, Hansraj N, Jambaulikar G, et al
    The Use of Temporary Fecal Diversion in Colonic and Perianal Crohn's Disease Does Not Improve Outcomes.
    Dig Dis Sci. 2017;62:2079-2086.
    PubMed     Text format     Abstract available


  100. JEWEL SAMADDER N, Valentine JF, Guthery S, Singh H, et al
    Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah.
    Dig Dis Sci. 2017;62:2126-2132.
    PubMed     Text format     Abstract available


    July 2017
  101. MOURAD FH, Yau Y, Wasinger VC, Leong RW, et al
    Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models.
    Dig Dis Sci. 2017 Jul 17. doi: 10.1007/s10620-017-4673.
    PubMed     Text format     Abstract available


  102. SARTINI A, Gitto S, Villa E
    Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients?
    Dig Dis Sci. 2017 Jul 4. doi: 10.1007/s10620-017-4665.
    PubMed     Text format    


    June 2017
  103. AGGARWAL S, Ahuja V, Paul J
    Attenuated GABAergic Signaling in Intestinal Epithelium Contributes to Pathogenesis of Ulcerative Colitis.
    Dig Dis Sci. 2017 Jun 30. doi: 10.1007/s10620-017-4662.
    PubMed     Text format     Abstract available


  104. SMITS LJT, Grelack A, Derikx LAAP, de Jong DJ, et al
    Long-Term Clinical Outcomes After Switching from Remicade(R) to Biosimilar CT-P13 in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Jun 30. doi: 10.1007/s10620-017-4661.
    PubMed     Text format     Abstract available


  105. ARGUELLES-ARIAS F, Guerra Veloz MF, Perea Amarillo R, Vilches-Arenas A, et al
    Erratum to: Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months.
    Dig Dis Sci. 2017 Jun 28. doi: 10.1007/s10620-017-4657.
    PubMed     Text format    


  106. KIM ES, Kim KO, Jang BI, Kim EY, et al
    Comparison of 4-L Polyethylene Glycol and 2-L Polyethylene Glycol Plus Ascorbic Acid in Patients with Inactive Ulcerative Colitis.
    Dig Dis Sci. 2017 Jun 21. doi: 10.1007/s10620-017-4634.
    PubMed     Text format     Abstract available


  107. ELURI S, Parian AM, Limketkai BN, Ha CY, et al
    Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Jun 19. doi: 10.1007/s10620-017-4652.
    PubMed     Text format     Abstract available


  108. LIU L, Li X
    NLRP3 Inflammasome in Inflammatory Bowel Disease: Friend or Foe?
    Dig Dis Sci. 2017 Jun 19. doi: 10.1007/s10620-017-4650.
    PubMed     Text format    


  109. JUNG YS, Han M, Kim WH, Park S, et al
    Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011-2014: A Nationwide Population-Based Study.
    Dig Dis Sci. 2017 Jun 7. doi: 10.1007/s10620-017-4640.
    PubMed     Text format     Abstract available


  110. FRIEDMAN S
    Gestational Weight Gain: A New Factor Influencing Pregnancy Outcomes in Women with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Jun 2. doi: 10.1007/s10620-017-4635.
    PubMed     Text format    


  111. LI J, Ueno A, Iacucci M, Fort Gasia M, et al
    Crossover Subsets of CD4+ T Lymphocytes in the Intestinal Lamina Propria of Patients with Crohn's Disease and Ulcerative Colitis.
    Dig Dis Sci. 2017 Jun 1. doi: 10.1007/s10620-017-4596.
    PubMed     Text format     Abstract available


  112. CAMPOS C, Perrey A, Lambert C, Pereira B, et al
    Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.
    Dig Dis Sci. 2017;62:1628-1636.
    PubMed     Text format     Abstract available


  113. OBI K, Hinton A, Sobotka L, Levine E, et al
    Hospital-Acquired Conditions Are Associated with Worse Outcomes in Crohn's Disease-Related Hospitalizations.
    Dig Dis Sci. 2017;62:1621-1627.
    PubMed     Text format     Abstract available


  114. NAFTALI T, Mechulam R, Marii A, Gabay G, et al
    Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial.
    Dig Dis Sci. 2017;62:1615-1620.
    PubMed     Text format     Abstract available


  115. KIM JW, Lee HS, Ye BD, Yang SK, et al
    Incidence of and Risk Factors for Free Bowel Perforation in Patients with Crohn's Disease.
    Dig Dis Sci. 2017;62:1607-1614.
    PubMed     Text format     Abstract available


  116. FUMERY M, Kohut M, Gower-Rousseau C, Duhamel A, et al
    Incidence, Clinical Presentation, and Associated Factors of Microscopic Colitis in Northern France: A Population-Based Study.
    Dig Dis Sci. 2017;62:1571-1579.
    PubMed     Text format     Abstract available


    May 2017
  117. MILLER TL, Lee D, Giefer M, Wahbeh G, et al
    Nutritional Therapy in Very Early-Onset Inflammatory Bowel Disease: A Case Report.
    Dig Dis Sci. 2017 May 27. doi: 10.1007/s10620-017-4616.
    PubMed     Text format     Abstract available


  118. TASSON L, Canova C, Vettorato MG, Savarino E, et al
    Influence of Diet on the Course of Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 May 26. doi: 10.1007/s10620-017-4620.
    PubMed     Text format     Abstract available


  119. RINAWI F, Assa A, Bashir H, Peleg S, et al
    Clinical and Phenotypic Differences in Inflammatory Bowel Disease Among Arab and Jewish Children in Israel.
    Dig Dis Sci. 2017 May 25. doi: 10.1007/s10620-017-4623.
    PubMed     Text format     Abstract available


  120. ZULLOW S, Jambaulikar G, Rustgi A, Quezada S, et al
    Risk Factors for Vitamin D Deficiency and Impact of Repletion in a Tertiary Care Inflammatory Bowel Disease Population.
    Dig Dis Sci. 2017 May 25. doi: 10.1007/s10620-017-4614.
    PubMed     Text format     Abstract available


  121. LAZARIDIS LD, Pistiki A, Giamarellos-Bourboulis EJ, Georgitsi M, et al
    Activation of NLRP3 Inflammasome in Inflammatory Bowel Disease: Differences Between Crohn's Disease and Ulcerative Colitis.
    Dig Dis Sci. 2017 May 18. doi: 10.1007/s10620-017-4609.
    PubMed     Text format     Abstract available


    April 2017
  122. MEIGHANI A, Hart BR, Bourgi K, Miller N, et al
    Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Apr 27. doi: 10.1007/s10620-017-4580.
    PubMed     Text format     Abstract available


  123. SAEZ-GONZALEZ E, Moret I, Alvarez-Sotomayor D, Diaz-Jaime FC, et al
    Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Apr 21. doi: 10.1007/s10620-017-4577.
    PubMed     Text format     Abstract available


  124. JIANG Y, Lin O, Sinha SR
    Use of Tumor Necrosis Factor Alpha Inhibitors for Inflammatory Bowel Disease Patients with Concurrent Heart Failure.
    Dig Dis Sci. 2017 Apr 17. doi: 10.1007/s10620-017-4574.
    PubMed     Text format     Abstract available


  125. PIECHOTA-POLANCZYK A, Wlodarczyk M, Sobolewska-Wlodarczyk A, Jonakowski M, et al
    Serum Cyclophilin A Correlates with Increased Tissue MMP-9 in Patients with Ulcerative Colitis, but Not with Crohn's Disease.
    Dig Dis Sci. 2017 Apr 8. doi: 10.1007/s10620-017-4568.
    PubMed     Text format     Abstract available


  126. CAO B, Zhou X, Ma J, Zhou W, et al
    Role of MiRNAs in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Apr 8. doi: 10.1007/s10620-017-4567.
    PubMed     Text format     Abstract available


  127. BARTELS LE, Dahlerup JF
    Association of Helicobacter pylori and Crohn's Disease Incidence: An Inversion Reaction?
    Dig Dis Sci. 2017 Apr 5. doi: 10.1007/s10620-017-4561.
    PubMed     Text format    


  128. ULLMAN TA, Itzkowitz SH
    Prognosis of Colorectal Cancer in Inflammatory Bowel Disease: Data from a State Registry.
    Dig Dis Sci. 2017 Apr 3. doi: 10.1007/s10620-017-4557.
    PubMed     Text format    


  129. HIRTEN R, Sands BE, Cohen BL
    The Whys and Hows of Fourth-Year Inflammatory Bowel Disease Fellowships.
    Dig Dis Sci. 2017 Apr 1. doi: 10.1007/s10620-017-4555.
    PubMed     Text format    


  130. SOFIA MA, Rubin DT
    The Impact of Therapeutic Antibodies on the Management of Digestive Diseases: History, Current Practice, and Future Directions.
    Dig Dis Sci. 2017;62:833-842.
    PubMed     Text format     Abstract available


  131. BENET-CAMPOS C, Cuellar C, Garcia-Ballesteros C, Zamora V, et al
    Determination of Anti-Anisakis Simplex Antibodies and Relationship with alphabeta and gammadelta Lymphocyte Subpopulations in Patients with Crohn's Disease.
    Dig Dis Sci. 2017;62:934-943.
    PubMed     Text format     Abstract available


  132. CAO Y, Ding Z, Han C, Shi H, et al
    Efficacy of Mesenchymal Stromal Cells for Fistula Treatment of Crohn's Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2017;62:851-860.
    PubMed     Text format     Abstract available


  133. KAUNITZ JD
    Development of Monoclonal Antibodies: The Dawn of mAb Rule.
    Dig Dis Sci. 2017;62:831-832.
    PubMed     Text format    


    March 2017
  134. ALLEGRETTI JR, Barnes EL, Stevens B, Storm M, et al
    Predictors of Clinical Response and Remission at 1 Year Among a Multicenter Cohort of Patients with Inflammatory Bowel Disease Treated with Vedolizumab.
    Dig Dis Sci. 2017 Mar 29. doi: 10.1007/s10620-017-4549.
    PubMed     Text format     Abstract available


  135. BENGTSON MB, Martin CF, Aamodt G, Vatn MH, et al
    Inadequate Gestational Weight Gain Predicts Adverse Pregnancy Outcomes in Mothers with Inflammatory Bowel Disease: Results from a Prospective US Pregnancy Cohort.
    Dig Dis Sci. 2017 Mar 22. doi: 10.1007/s10620-017-4547.
    PubMed     Text format     Abstract available


  136. KHAN N, Patel D, Shah Y, Yang YX, et al
    A Novel Model for Predicting Incident Moderate to Severe Anemia and Iron Deficiency in Patients with Newly Diagnosed Ulcerative Colitis.
    Dig Dis Sci. 2017 Mar 11. doi: 10.1007/s10620-017-4512.
    PubMed     Text format     Abstract available


  137. ARGUELLES-ARIAS F, Guerra Veloz MF, Perea Amarillo R, Vilches-Arenas A, et al
    Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months.
    Dig Dis Sci. 2017 Mar 9. doi: 10.1007/s10620-017-4511.
    PubMed     Text format     Abstract available


  138. CARR RM, Patel A, Bownik H, Oranu A, et al
    Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2017 Mar 6. doi: 10.1007/s10620-017-4495.
    PubMed     Text format     Abstract available


  139. BOLTIN D, Kamenetsky Z, Perets TT, Snir Y, et al
    Circulating Bone Marrow-Derived CD45-/CD34+/CD133+/VEGF+ Endothelial Progenitor Cells in Adults with Crohn's Disease.
    Dig Dis Sci. 2017;62:633-638.
    PubMed     Text format     Abstract available


  140. DIETRICH C, Singh SR
    Circulating Endothelial Progenitor Cells in Crohn's Disease: An EPiC in the Making?
    Dig Dis Sci. 2017;62:567-568.
    PubMed     Text format    


  141. TRIADAFILOPOULOS G, Eisenstat S, Dormady S, Sinha R, et al
    When It Rains It Pours: Evolving, Complicated Small Intestinal Crohn's Disease.
    Dig Dis Sci. 2017;62:577-582.
    PubMed     Text format    


    February 2017
  142. RAI T, Choudhury BN, Kedia S, Bopanna S, et al
    Short-Term Clinical Response to Corticosteroids Can Predict Long-Term Natural History of Ulcerative Colitis: Prospective Study Experience.
    Dig Dis Sci. 2017 Feb 4. doi: 10.1007/s10620-017-4450.
    PubMed     Text format     Abstract available


  143. NARULA N, Cooray M, Anglin R, Muqtadir Z, et al
    Impact of High-Dose Vitamin D3 Supplementation in Patients with Crohn's Disease in Remission: A Pilot Randomized Double-Blind Controlled Study.
    Dig Dis Sci. 2017;62:448-455.
    PubMed     Text format     Abstract available


  144. BODELIER AG, Jonkers D, van den Heuvel T, de Boer E, et al
    High Percentage of IBD Patients with Indefinite Fecal Calprotectin Levels: Additional Value of a Combination Score.
    Dig Dis Sci. 2017;62:465-472.
    PubMed     Text format     Abstract available


  145. KOTZE PG, Saab MP, Saab B, da Silva Kotze LM, et al
    Tumor Necrosis Factor Alpha Inhibitors Did Not Influence Postoperative Morbidity After Elective Surgical Resections in Crohn's Disease.
    Dig Dis Sci. 2017;62:456-464.
    PubMed     Text format     Abstract available


    January 2017
  146. SCAIOLI E, Sartini A, Liverani E, Digby RJ, et al
    Sulfasalazine in Prevention of Pouchitis After Proctocolectomy with Ileal Pouch-Anal Anastomosis for Ulcerative Colitis.
    Dig Dis Sci. 2017 Jan 21. doi: 10.1007/s10620-017-4454.
    PubMed     Text format     Abstract available


  147. LEE HS, Lim YJ, Shim KN, Moon CM, et al
    Diagnostic Value of Small Bowel Capsule Endoscopy in Isolated Ileitis: A CAPENTRY Study.
    Dig Dis Sci. 2017;62:180-187.
    PubMed     Text format     Abstract available


  148. SRIDHAR A, Cwiak CA, Kaunitz AM, Allen RH, et al
    Contraceptive Considerations for Women with Gastrointestinal Disorders.
    Dig Dis Sci. 2017;62:54-63.
    PubMed     Text format     Abstract available


  149. STEVENS BW, Borren NZ, Velonias G, Conway G, et al
    Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2017;62:197-206.
    PubMed     Text format     Abstract available


  150. FORTINSKY KJ, Kevans D, Qiang J, Xu W, et al
    Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn's Disease.
    Dig Dis Sci. 2017;62:188-196.
    PubMed     Text format     Abstract available


  151. XIE M, Qin H, Luo Q, He X, et al
    Comparison of Adipose-Derived and Bone Marrow Mesenchymal Stromal Cells in a Murine Model of Crohn's Disease.
    Dig Dis Sci. 2017;62:115-123.
    PubMed     Text format     Abstract available


  152. REGALIA K, Shelton A, Berry G, Triadafilopoulos G, et al
    Pulmonary Crohn's Disease.
    Dig Dis Sci. 2017;62:64-67.
    PubMed     Text format    


    December 2016
  153. TAKAHARA I, Takeshima F, Ichikawa T, Matsuzaki T, et al
    Prevalence of Restless Legs Syndrome in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2016 Dec 29. doi: 10.1007/s10620-016-4420.
    PubMed     Text format     Abstract available


  154. KORELITZ BI
    Enduring Value of Thiopurines for Inflammatory Bowel Disease Therapy.
    Dig Dis Sci. 2016 Dec 26. doi: 10.1007/s10620-016-4419.
    PubMed     Text format    


  155. TAN MC, El-Serag HB, Hou JK
    Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease.
    Dig Dis Sci. 2016 Dec 23. doi: 10.1007/s10620-016-4414.
    PubMed     Text format     Abstract available


  156. BERNSTEIN GR, Pickett-Blakely O
    De Novo Inflammatory Bowel Disease After Bariatric Surgery: A Case Series and Literature Review.
    Dig Dis Sci. 2016 Dec 23. doi: 10.1007/s10620-016-4412.
    PubMed     Text format    


  157. TAXONERA C, Iglesias E, Munoz F, Calvo M, et al
    Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  158. FEUERSTEIN JD, Sehgal P, Rao V, Malladi VR, et al
    Inflammatory Bowel Disease-Related Abstracts Presented at National Conferences in the USA Are Frequently Unpublished as Full Manuscripts.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  159. WANNHOFF A, Rupp C, Friedrich K, Knierim J, et al
    Carcinoembryonic Antigen Level in Primary Sclerosing Cholangitis Is Not Influenced by Dominant Strictures or Bacterial Cholangitis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    November 2016
  160. PRIEUX-KLOTZ C, Nahon S, Amiot A, Sinayoko L, et al
    Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  161. LOPEZ-SANROMAN A, Carpio D, Calvet X, Romero C, et al
    Perceived Emotional and Psychological Impact of Ulcerative Colitis on Outpatients in Spain: UC-LIFE Survey.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    October 2016
  162. PADHAN RK, Kedia S, Garg SK, Bopanna S, et al
    Long-Term Disease Course and Pregnancy Outcomes in Women with Inflammatory Bowel Disease: An Indian Cohort Study.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  163. LATUSHKO A, Ghazi LJ
    A Case of Thiopurine-Induced Acute Myocarditis in a Patient with Ulcerative Colitis.
    Dig Dis Sci. 2016.
    PubMed     Text format    


  164. COLOM-STEELE D, Castresana D, Hanson J, Parasher G, et al
    A Rare Case of Invasive Pancreatitis in an Immunocompromised Host.
    Dig Dis Sci. 2016.
    PubMed     Text format    


    September 2016
  165. BARNES EL, Goldin A, Winter RW, Collins E, et al
    Sequential Combination Therapy Versus Monotherapy: A Lack of Benefit in Time to Inflammatory Bowel Disease-Related Surgery.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  166. SUSKIND DL, Wahbeh G, Cohen SA, Damman CJ, et al
    Patients Perceive Clinical Benefit with the Specific Carbohydrate Diet for Inflammatory Bowel Disease.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  167. ANDERSON AJ, Click B, Ramos-Rivers C, Babichenko D, et al
    Development of an Inflammatory Bowel Disease Research Registry Derived from Observational Electronic Health Record Data for Comprehensive Clinical Phenotyping.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    April 2016
  168. LIU JJ, Kay TM, Davis EM, Lou Y, et al
    Epithelial Cell Extrusion Zones Observed on Confocal Laser Endomicroscopy Correlates with Immunohistochemical Staining of Mucosal Biopsy Samples.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  169. LEE D, Suskind D
    Individualized Food-Based Dietary Therapy for Crohn's Disease: Are We Making Progress?
    Dig Dis Sci. 2016;61:958-60.
    PubMed     Text format    


    March 2016
  170. PAUL S, Shuja A, Tam I, Kim EM, et al
    Gastroenterologists Have Suboptimal Hepatitis B Virus Screening Rates in Patients Receiving Immunosuppressive Therapy.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: